Author

Eivind Berge

Observed names: E Berge, E. Berge

Observed institutions: Oslo University Hospital, State University of New York, SUNY Downstate Health Sciences University, University of Oslo, University of Michigan, University of Oxford, OLVG, Sir Ganga Ram Hospital, IRCCS Istituto Auxologico Italiano, KLE Society Hospital, Stanford Medicine, Imperial College London, University of Milano-Bicocca

OpenAlex ID: A5108709960

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

2021 · Kazem Rahimi, Zeinab Bidel, et al. · The Lancet · 1,110

PDF

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

2021 · Kazem Rahimi, Zeinab Bidel, et al. · The Lancet · 344

PDF

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

2016 · A John Camm, Gabriele Accetta, et al. · Heart · 241

PDF

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks

2017 · Maria H Mehlum, Knut Liestøl, et al. · European Heart Journal · 227

PDF

Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline

2019 · Catharina JM Klijn, Maurizio Paciaroni, et al. · European Stroke Journal · 213

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data

2018 · Kunal N. Karmali, Donald M. Lloyd-Jones, et al. · PLoS Medicine · 122

PDF

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

2022 · Milad Nazarzadeh, Zeinab Bidel, et al. · The Lancet Diabetes & Endocrinology · 112

PDF

Blood pressure and hypertension in athletes: a systematic review

2015 · H M Berge, C B Isern, et al. · British Journal of Sports Medicine · 109

PDF

Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation

2013 · Karsten MH Bruins Slot, Eivind Berge · Cochrane Database of Systematic Reviews · 107

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial

2015 · Sverre E. Kjeldsen, Eivind Berge, et al. · Blood Pressure · 75

PDF

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient

2014 · Alberto Zanchetti, Lisheng Liu, et al. · Journal of Hypertension · 75

Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation

2018 · Karsten MH Bruins Slot, Eivind Berge · Cochrane Database of Systematic Reviews · 66

PDF

Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation

2013 · Karsten M.H. Bruins Slot, Eivind Berge · Stroke · 65

PDF

Change in Cardiorespiratory Fitness and Risk of Stroke and Death

2018 · Erik Prestgaard, Julian Mariampillai, et al. · Stroke · 58

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

2019 · Shinya Goto, Pantep Angchaisuksiri, et al. · Journal of the American Heart Association · 53

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean

2018 · Abdul Salam, Emily Atkins, et al. · Journal of Hypertension · 50

PDF

The Factor V Leiden, Prothrombin Gene 20210GA, Methylenetetrahydrofolate Reductase 677CT and Platelet Glycoprotein IIIa 1565TC Mutations in Patients With Acute Ischemic Stroke and Atrial Fibrillation

2007 · Eivind Berge, Kari Bente Foss Haug, et al. · Stroke · 41

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline

2014 · Alberto Zanchetti, Lisheng Liu, et al. · Journal of Hypertension · 39

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events

2019 · Dan Atar, Eivind Berge, et al. · EP Europace · 36

PDF

Adaptation of Trustworthy Guidelines Developed Using the GRADE Methodology

2014 · Annette Kristiansen, Linn Brandt, et al. · CHEST Journal · 30

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT

2016 · Alberto Zanchetti, Lisheng Liu, et al. · Journal of Hypertension · 29

Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin?

2006 · Martin J. O’Donnell, Eivind Berge, et al. · Stroke · 28

Change in Body Weight and Long-Term Risk of Stroke and Death in Healthy Men

2020 · Erik Prestgaard, Julian Mariampillai, et al. · Stroke · 21

PDF

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

2018 · Jitendra PS. Sawhney, Veerappa A. Kothiwale, et al. · Indian Heart Journal · 21

PDF

Blood Pressure–Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers

2020 · Maria H. Mehlum, Knut Liestøl, et al. · Hypertension · 18

PDF

Works count: 72

Citation count: 3,411

H-index: 22

I10-index: 30